Tag: 105M
Attovia Therapeutics Raises $105M in Series B Financing
Attovia Therapeutics, a Fremont, CA-based developer of a pipeline of biotherapeutics with an preliminary concentrate on immune-mediated ailments,…
Cour Pharmaceuticals Closes Approximately $105M Series A Funding
Cour Pharmaceuticals, a Chicago, IL-based clinical-stage biotechnology company, raised approximately $105M Series A funding. The round was led…